EGFR amplification is a putative resistance mechanism for NSCLC–LM patients with TKI therapy and is associated with poor outcome

BACKGROUND: Leptomeningeal metastases (LM) have become increasingly common in non-small cell lung cancer (NSCLC) patients who harbor epidermal growth factor receptor (EGFR) mutation treated with EGFR-TKI and are correlated with inferior prognosis. Evidence in prior research demonstrated that EGFR am...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hainan, Wen, Lei, Zhao, Chao, Li, Xuefei, Shan, Changguo, Liu, Da, Hong, Weiping, Zhou, Zhaoming, Zhou, Cheng, Cai, Linbo, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376465/
https://www.ncbi.nlm.nih.gov/pubmed/35978803
http://dx.doi.org/10.3389/fonc.2022.902664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376465/
https://www.ncbi.nlm.nih.gov/pubmed/35978803
http://dx.doi.org/10.3389/fonc.2022.902664

Ejemplares similares